Literature DB >> 22988651

Acneiform eruptions induced by epidermal growth factor receptor inhibitors: treatment with oral isotretinoin.

Celia Requena1, Beatriz Llombart, Onofre Sanmartín.   

Abstract

The most common cutaneous side effects to epidermal growth factor receptor (EGFR) inhibitors are follicular or acneiform eruptions, nail disorders, xerosis, and desquamation. Although topical and oral antibiotics with or without topical corticosteroids usually are safe and effective treatment options for acneiform eruptions due to EGFR inhibitors, they are not always successful in refractory cases. We report 3 cases of severe acneiform eruptions induced by EGFR inhibitors that were successfully treated with oral isotretinoin. Complete response was observed in all 3 patients. We recommend oral isotretinoin for the management of acneiform reactions to EGFR inhibitors when the lesions persist or worsen despite antibiotic treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22988651

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  6 in total

1.  A review of cutaneous toxicities from targeted therapies in the treatment of colorectal cancers.

Authors:  Christopher Urban; Milan J Anadkat
Journal:  J Gastrointest Oncol       Date:  2013-09

Review 2.  Tyrosine kinase inhibitors: their on-target toxicities as potential indicators of efficacy.

Authors:  Devron R Shah; Rashmi R Shah; Joel Morganroth
Journal:  Drug Saf       Date:  2013-06       Impact factor: 5.606

Review 3.  Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel.

Authors:  Jade Cury-Martins; Adriana Pessoa Mendes Eris; Cristina Martinez Zugaib Abdalla; Giselle de Barros Silva; Veronica Paula Torel de Moura; Jose Antonio Sanches
Journal:  An Bras Dermatol       Date:  2020-02-15       Impact factor: 1.896

Review 4.  Cutaneous adverse reactions specific to epidermal growth factor receptor inhibitors.

Authors:  I Lupu; V M Voiculescu; N Bacalbasa; B E Prie; I Cojocaru; C Giurcaneanu
Journal:  J Med Life       Date:  2015

Review 5.  Novel medical strategies combating nonmelanoma skin cancer.

Authors:  Prasan R Bhandari; Varadraj V Pai
Journal:  Indian J Dermatol       Date:  2014-11       Impact factor: 1.494

Review 6.  Dermatologic conditions in women receiving systemic cancer therapy.

Authors:  Michelle N Ferreira; Julie Y Ramseier; Jonathan S Leventhal
Journal:  Int J Womens Dermatol       Date:  2019-11-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.